
51 - 200 employees
Founded 2021
𧬠Biotechnology
π Pharmaceuticals
π₯ Healthcare
Biotechnology β’ Pharmaceuticals β’ Healthcare
Alumis is a late-stage biopharmaceutical company developing next-generation targeted therapies for immune-mediated diseases. The company advances a precision approach built on integrated scientific insights and a proprietary data analytics platform to guide therapeutic development. Alumis' pipeline includes envudeucitinib (being studied in psoriasis and systemic lupus erythematosus) and lonigutamab (A-005), and it runs clinical trials and patient resources for conditions such as psoriasis, SLE, and thyroid eye disease. The company is headquartered in South San Francisco, CA and emphasizes transforming treatments to improve patient outcomes.
π₯ 15 hours ago
πΊπΈ United States β Remote
π΅ $200k - $265k / year
β° Full Time
π‘ Mid-level
π Senior
π» Ghost score 0%
Where this job comes from
Posted on Alumis's careers page β, not through a job board
First seen by Remote Rocketship 15 hours ago
Still open on Alumis's site. Checked 40 minutes ago.

51 - 200 employees
Founded 2021
𧬠Biotechnology
π Pharmaceuticals
π₯ Healthcare
Biotechnology β’ Pharmaceuticals β’ Healthcare
Alumis is a late-stage biopharmaceutical company developing next-generation targeted therapies for immune-mediated diseases. The company advances a precision approach built on integrated scientific insights and a proprietary data analytics platform to guide therapeutic development. Alumis' pipeline includes envudeucitinib (being studied in psoriasis and systemic lupus erythematosus) and lonigutamab (A-005), and it runs clinical trials and patient resources for conditions such as psoriasis, SLE, and thyroid eye disease. The company is headquartered in South San Francisco, CA and emphasizes transforming treatments to improve patient outcomes.
β’ Build and maintain relationships with payers, PBMs, and health systems β’ Deliver clinical, real-world, and health economic evidence to inform access decisions β’ Support payer engagement strategy, including pre-launch activities and value communication β’ Contribute to HEOR and evidence generation plans, including AMCP dossier support β’ Gather insights on payer needs and market dynamics to inform strategy β’ Collaborate cross-functionally with Medical Affairs, HEOR, and Market Access teams β’ Engage payers and healthcare decision makers β’ Communicate the clinical and economic value of Alumis therapies to support formulary access, reimbursement, and patient outcomes β’ Translate clinical and HEOR evidence into meaningful value narratives for population-based stakeholders
β’ Advanced degree required (PharmD, PhD, MD, MPH, or equivalent) β’ 5+ years of experience in Medical Affairs, HEOR, Market Access, or related field β’ Experience engaging payers or healthcare decision makers strongly preferred β’ Strong understanding of HEOR, RWE, and U.S. payer landscape β’ Excellent communication and stakeholder engagement skills β’ Ability to translate complex data into clear, payer-relevant value insights β’ Strong collaboration skills in a cross-functional, fast-paced environment β’ Strategic mindset with a focus on value-based care and patient access
β’ Generous stock option grants for all employees β’ Annual bonus program β’ Health insurance premiums paid at 90% for employee, 80% for dependents β’ Free access to Genentech Bus & Ferry Share program β’ $100 monthly cell phone stipend β’ Unlimited PTO for Exempt employees β’ Free onsite gym and a kitchen stocked with yummy snacks and drinks!
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π 6 days ago
Medical Value & Access Liaison advancing Amgen medicines through clinical, economic, and reimbursement presentations to national U.S. payer accounts. Leading value-access strategies and evidence partnerships.
πΊπΈ United States β Remote
π΅ $157.8k - $213.5k / year
π° $28.5G Post-IPO Debt on 2022-12
β° Full Time
π Senior
π¦ H1B Visa Sponsor
π 6 days ago
Medical Value & Access Liaison advancing Amgen medicines through payer evidence, access strategies, and health economics partnerships. Field-based role supporting national U.S. accounts.
πΊπΈ United States β Remote
π΅ $157.8k - $213.5k / year
π° $28.5G Post-IPO Debt on 2022-12
β° Full Time
π‘ Mid-level
π Senior
π¦ H1B Visa Sponsor
π 6 days ago
Medical Value & Access Liaison advancing Amgen medicines through payer evidence, reimbursement strategy, and population-health partnerships. National field role supporting strategic U.S. accounts.
πΊπΈ United States β Remote
π΅ $157.8k - $213.5k / year
π° $28.5G Post-IPO Debt on 2022-12
β° Full Time
π‘ Mid-level
π Senior
π¦ H1B Visa Sponsor
π 6 days ago
Medical Value & Access Liaison advancing Amgenβs biotech medicines through payer presentations, access strategies, and evidence partnerships. Supporting national Cigna/ESI accounts across the U.S.
πΊπΈ United States β Remote
π΅ $157.8k - $213.5k / year
π° $28.5G Post-IPO Debt on 2022-12
β° Full Time
π‘ Mid-level
π Senior
π¦ H1B Visa Sponsor
π October 6
Senior Medical Science Liaison advancing Aquestive Therapeuticsβ pharmaceutical products and scientific relationships. Managing KOL engagement and medical initiatives across the Mid Atlantic region.